Original Article
Mediastinoscopy Trends and Practice Patterns in the United States
Abstract
Objectives: Historically, mediastinoscopy has been the gold standard for the staging of lung cancer. A practice gap exists as the result of a variation in knowledge concerning current trends and practice patterns of mediastinoscopy usage. In addition, there are regional variations in practice-based learning and patient care. Lessons learned during surgeries performed on patients with lung cancer and other advances such as positron emission tomography and endobronchial ultrasound could be universally applied to improve surgeons’ management of patient care. The purpose of this study was to assess contemporary practices in the staging of lung cancer.Methods: We queried the Society of Thoracic Surgeons National Database for data regarding mediastinoscopy usage, yield, and variation, both by year and region.
Results: Cases with mediastinoscopy, as a percentage of all cases performed in the database, have significantly decreased from 14.6% in 2006 to 11.4% in 2010 (P < 0.001). The 5-year median rate of mediastinoscopy in lung cancer patients at 163 centers was 15.3% (interquartile range 5.2%–31.7%), indicating significant variation among centers. The overall median center rate also decreased over time from 21.4% (2006) to 10.0% (2010).
Conclusions: With advances in minimally invasive procedures and imaging, mediastinoscopy usage has declined significantly. Our findings are likely to be relevant to both clinical practice and practice guidelines.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Carlens E. Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum. Dis Chest. 1959; 36: 343–352.
2. Reynders H. Mediastinoscopy in bronchogenic cancer. Dis Chest. 1964; 45: 606–611.
3. Sarin CL, Nohl-Oser HC. Mediastinoscopy: a clinical evaluation of 400 consecutive cases. Thorax. 1969; 24: 585–588.
4. Whitcomb ME, Barham E, Goldman AL, et al. Indications for mediastinoscopy in bronchogenic carcinoma. Am Rev Respir Dis. 1976; 113: 189–195.
5. Martin LW, Correa AM, Hofstetter W, et al. The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg. 2005; 130: 1601–1610.
6. Lerut T, De Leyn P, Coosemans W, et al. Cervical videomediastinoscopy. Thorac Surg Clin. 2010; 20: 195–206.
7. Sortini A, Navarra G, Santini M, et al. [Video-assisted mediastinoscopy. A new application of television technology in surgery]. Minerva Chir. 1994; 49: 803–805.
8. Edwards FH. Evolution of the Society of Thoracic Surgeons National Cardiac Surgery Database. J Invasive Cardiol. 1998; 10: 485–488.
9. Luke WP, Pearson FG, Todd TR, et al. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg. 1986; 91: 53–56.
10. Paleru C, Dănăilă O, Bolca C, et al. [Complications of mediastinoscopy]. Pneumologia. 2009; 58: 39–40.
11. Cho JH, Kim J, Kim K, et al. A comparative analysis of video-assisted mediastinoscopy and conventional mediastinoscopy. Ann Thorac Surg. 2011; 92: 1007–1011.
12. Anraku M, Miyata R, Compeau C, et al. Video-assisted mediastinoscopy compared with conventional mediastinoscopy: are we doing better? Ann Thorac Surg. 2010; 89: 1577–1581.
13. Zakkar M, Tan C, Hunt I. Is video mediastinoscopy a safer and more effective procedure than conventional mediastinoscopy? Interact Cardiovasc Thorac Surg. 2012; 14: 81–84.
14. Zakkar M, Hunt I. Complication rates in mediastinoscopy and training: video versus conventional mediastinoscopy. Ann Thorac Surg. 2012; 94: 337
15. Lee BE, von Haag D, Lown T, et al. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007; 133: 746–752.
16. Shrager JB. Mediastinoscopy: still the gold standard. Ann Thorac Surg. 2010; 89: S2084–S2089.
17. Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006; 82: 1185–1190.
18. Schouwink JH, Kool LS, Rutgers EJ, et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg. 2003; 75: 1715–1718.
19. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007; 32: 1–8.
20. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132: 202S–220S.
21. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006; 130: 710–718.
22. Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience from 240 consecutive cases. Ann Thorac Surg. 2003; 76: 208–212.
23. Whitson BA, Groth SS, Maddaus MA. Recommendations for optimal use of imaging studies to clinically stage mediastinal lymph nodes in non-small-cell lung cancer patients. Lung Cancer. 2008; 61: 177–185.
24.Deleted in proof.
25. Graeter TP, Hellwig D, Hoffmann K, et al. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Annals Thorac Surg. 2003; 75: 231–236.
26. Gonzalez-Stawinski GV, Lemaire A, Merchant F, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003; 126: 1900–1904.
27. Scott WJ, Gobar LS, Terry JD. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg. 1996; 111: 642–648.
28. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT1. Radiology. 1999; 213: 530–536.
29. Farrell MA, McAdams HP, Herndon JE, et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology. 2000; 215: 886–890.
30. Boiselle PM, Patz EF Jr, Vining DJ, et al. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics. 1998; 18: 1061–1069.
31. Poncelet AJ, Lonneux M, Coche E, et al. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Eur J Cardiothorac Surg. 2001; 20: 468–474.
32. Chang JM, Lee HJ, Goo JM, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006; 7: 57–69.
33. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CET. N Engl J Med. 2009; 361: 32–39.
34. Vilmann P, Puri R. The complete “medical mediastinoscopy” (EUS-FNA + EBUS-TBNA). Minerva Med. 2007; 98: 331–338.
35. Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011; 142: 1393–1400.
36. Tahara RW, Lackner RP, Graver LM. Is there a role for routine media stinoscopy in patients with peripheral T1 lung cancers? Am J Surg. 2000; 180: 488–491.
37. Dhillon SS, Dhillon JK, Yendamuri S. Mediastinal staging of non-small-cell lung cancer. Expert Rev Respir Med. 2011; 5: 835–850.
